← Open Payments lookup

JEAN EVANS: Open Payments

NPI 1649894908 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$477 in 21 payments from 12 companies in 2025. Trend: 2023 $86 · 2024 $450 · 2025 $477

Food & beverage: $477
CompanyPaymentsAmount
ABBVIE INC.5$142
AstraZeneca Pharmaceuticals LP3$77
Novo Nordisk Inc2$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$41
Merck Sharp & Dohme LLC2$41
Sumitomo Pharma America, Inc.1$22
SHIELD THERAPEUTICS INC1$21
Phadia US Inc.1$19
Amneal Pharmaceuticals LLC1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: QULIPTA, FARXIGA, XIFAXAN, GARDASIL 9, UBRELVY, Ozempic, GEMTESA, ACCRUFER.

Industry payments across NC — which companies pay providers there.